4//SEC Filing
Kadlec Robert Peter 4
Accession 0001193125-25-201318
CIK 0001840229other
Filed
Sep 10, 8:00 PM ET
Accepted
Sep 11, 4:05 PM ET
Size
5.3 KB
Accession
0001193125-25-201318
Insider Transaction Report
Form 4
Kadlec Robert Peter
Director
Transactions
- Award
Stock Option (Right to Buy)
2025-09-09+3,225→ 3,225 totalExercise: $15.36Exp: 2035-09-09→ Common Stock (3,225 underlying)
Footnotes (1)
- [F1]The option vests in full on the one-year anniversary of the date of grant, provided that the Reporting Person continues to serve on the Issuer's Board of Directors through such date.
Documents
Issuer
MiNK Therapeutics, Inc.
CIK 0001840229
Entity typeother
Related Parties
1- filerCIK 0002047073
Filing Metadata
- Form type
- 4
- Filed
- Sep 10, 8:00 PM ET
- Accepted
- Sep 11, 4:05 PM ET
- Size
- 5.3 KB